Navigation Links
The surprising story of Charles Darwin and his homeopathic doctor
Date:12/12/2007

A new scholarly written book describes hundreds of well-known and respected physicians, scientists, politicians, corporate leaders, and literary greats who used or advocated for homeopathic medicine. Eleven U.S. Presidents, seven popes, Sir William Osler, J.D. Rockefeller, Charles Kettering, and C. Everett Koop are among those famous people who were known to have benefited from homeopathy. Perhaps most surprisingly is the evidence of Charles Darwins use of homeopathic medicines and the significant results he received from them.

In the new book, The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy (North Atlantic Books, 2007), Dana Ullman presents strong evidence derived primarily from Charles Darwins own letters about the treatment he received from a homeopathic physician. Ullman suggests that Charles Darwin would not have lived long enough to have completed his seminal work, The Origin of Species, in 1859 if he didnt get homeopathic treatment ten years previously.

It is well known that Darwin became very ill during his trip to South America in the late 1830s. His health continued to decline, and he was so ill that he couldnt attend his own fathers funeral in 1848. He suffered from severe and constant nausea, heart palpitations, widespread boils, and trembling for 12 years, and by 1849, he had suffered from fainting spells and spots before his eyes for two years. According to Darwins letters, he was not able to work one day in every three.

Finally, in 1849, he sought the treatment from Dr. James Manby Gully, a homeopathic physician who owned a hydrotherapy spa. Although Darwin was skeptical of homeopathy, he obediently took the prescription of homeopathic medicines his doctor gave him, and within a month, his health was considerably better. Darwin didnt have nausea for a month, gained some weight, took a seven mile walk (which he was previously unable to do), and then wrote to a friend, I
'/>"/>

Contact: Dean Draznin
dean@drazninpr.com
641-472-2257
Foundation for Homeopathic Education and Research
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. European Union forests expanding, absorbing carbon at surprisingly high rate: study
2. Story ideas from the Journal of Lipid Research
3. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
4. Satellites witness lowest Arctic ice coverage in history
5. Census of protein architectures offers new view of history of life
6. New study sheds light on Galápagos hawk evolutionary history
7. Microfossils disclose geologic history of eastern California
8. Story ideas from Molecular & Cellular Proteomics
9. Story tips from the Department of Energys Oak Ridge National Laboratory, October 2007
10. Story ideas from the Journal of Biological Chemistry
11. Rebuilding the evolutionary history of HIV-1 unravels a complex loop

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...e of day matters to forest trees dealing with drou...ch team led by Professor Malcolm Campbell, Univers...search and colleagues in the department of cell an...Capitalizing on their previous work to decode the ...ned how poplar trees use their 45,000 genes to res...
(Date:11/23/2009)...ipants gathered this week for the seventh annual N...ce. This year,s topic, "Synthetic Biology," brough...archers to explore the engineering, scientific, an...synthetic biology. , Bonnie L. Bassler, professo... this year,s conference chair, challenged the atte...
(Date:11/23/2009)...s "incontrovertible evidence" that the volcanic su...t 73,000 years ago deforested much of central Indi...s report. , The volcano ejected an estimated 800...ing a crater (now the world,s largest volcanic lak...ide. Ash from the event has been found in India, t...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 1Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 2Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 3Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 1Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 2Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 3RainEarth Obtains Patent Approvals for Its Core Technology 50153 1RainEarth Obtains Patent Approvals for Its Core Technology 50153 2RainEarth Obtains Patent Approvals for Its Core Technology 50153 3
...ornia,s Viterbi School of Engineering have success...onic Transmission Tomography" (HUTT) system that o...o those produced by existing commercial X-ray, ult...essor of biomedical engineering at the Viterbi Sch...in San Diego at the 28th International Acoustical ...
...iversity of Melbourne, Australia, has conducted th...volution of one of nature,s most sophisticated bio...the March issue of the journal Genome Research. , ...amily Colubroidea, evolved glands for the storage ...million years ago. Since that time, various prey-i...
...tes stem from bat bites, far more people are treat...e list of most often reported rabid mammal. Contro...he spatial dynamics of the disease - where new out... In a new study reported in the freely-available o...ply a mathematical model to predict the likely spr...
Other Biology News:A probe, not an echo 2A probe, not an echo 3A probe, not an echo 4Venom doc tracks down snake bioweapons 2Rabies spread speeds up 2
(Date:11/24/2009)...AI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannounc...)hasapprovedthe,investigationalnewdrugapplication(...insulinformulationtotreatdiabetes.ThisIND,approval.... , Diabetesisadisordercharacteristicofhighbl...betesoftenresultinseveremicro-and,macro-vasculardi...
(Date:11/24/2009)... The FBI recently approved the Promega ...ticipating in or generating DNA records for the Na... Madison, WI USA (PRWEB) -- The FBI recently appr... use by laboratories participating in, or generati...(NDIS). NDIS currently contains more than seven mi...
(Date:11/24/2009)...TURE:HTL , TORONTO,Nov.24/PRNewswire-FirstCal...pitalInc.,aleadingproviderofadvancedlasersystemsan...icmarkets,todayreportedoperationalandfinancialresu...2009Highlights,-Revenuewas$1.46millioncomparedwit...centcomparedwith66.1percentinQ3,2008,-Netlossreduc...
(Date:11/24/2009)...GO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPharmac...ecompanyisscheduledtopresentatthePiperJaffray21stA...m.EasternTime(8:30a.m.PacificTime)attheNewYorkPala...dChiefExecutiveOfficer,isscheduledtoprovideanoverv...discoveryprograms. ,, Aliveaudiowebcastofthepre...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...O, Oct. 14 Nile Therapeutics,Inc. (Nasdaq: NLTX ...ter,open-label Phase 2a clinical study of CD-NP, a...ospitalized for acute heart failure., -- Statis...ry wedge pressure -- Statistically signific...on in right atrial pressure -- Trend toward incr...
...pport creation of market incentives and facilitate...O Ventures for Global,Health (BVGH) today announce...anded its support of the organization, so it can f... create new medicines for infectious,diseases of t...p BVGH build,the market case for biotechnology ind...
...ct. 14 Althea Technologies, Inc., a leading,provi...armaceutical,development and manufacturing, announ...fast growth awards, Deloitte LLP,s San Diego Techn...00 Fastest Growing Private Companies,for the fifth... is an,annual ranking of the 50 fastest growing te...
Other Biology Technology:Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 2Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 3Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 4Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 5BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World 2Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year 2
Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from Abcam
Rabbit Anti-13,14 dihydro 15 keto Prostaglandin E2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human DDO Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-Arginine Vasopressin Receptor Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: